INVESTING IN THE AGE OF LONGEVITY

13 November 2019, Science Gallery, London

CONNECT, COLLABORATE, INVEST

The science of ageing is progressing rapidly and with it comes a new industry, with hundreds of early stage companies now in existence and the first publicly listed companies beginning to appear.

Master Investor’s one day masterclass, Investing in the Age of Longevity, aims to bring together investors, advisors, academia and businesses working in the field of Longevity to provide an independent and powerful platform to showcase the latest innovations in this field with a view to fostering collaboration and exploring investment opportunities.

WHY ATTEND?

Network with investors and experts in the field of longevity.

Be the first to learn about opportunities to invest in this space.

Strengthen your IR activities by connecting with retail investors.
Generate new leads for fundraising and/or selling your products or services.
SPEAKERS

Dr. Aubrey de Grey

Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501(c)(3) biomedical research charity that performs and funds laboratory research dedicated to combating the aging process. He is also VP of New Technology Discovery at AgeX Therapeutics, a biotechnology startup developing new therapies in the field of biomedical gerontology. In addition, he is Editor-in-Chief of Rejuvenation Research, the world’s highest-impact peer-reviewed journal focused on intervention in aging. 

He received his BA in computer science and Ph.D. in biology from the University of Cambridge. His research interests encompass the characterisation of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage.

Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organisations. He is a highly sought-after speaker who gives 40-50 invited talks per year at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public.

Nir Barzilai MD

Dr. Barzilai is a chaired Professor of Medicine and Genetics and Director of the biggest Center in the world to study the Biology of Aging. He is the recipient of an NIH Merit Award aiming to extend the healthy life span in rodents by biological interventions. He also studies families of centenarians that have provided genetic/biological insights on the protection against aging. Several drugs are developed based, in part, on these paradigm-changing studies. He is a recipient of numerous prestigious awards, including the recipient of the 2010 Irving S. Wright Award of Distinction in Aging Research and is the 2018 recipient of the IPSEN Longevity award. He is leading the TAME (Targeting/Taming Aging with Metformin) multi central study to prove that concept that multi morbidities of aging can be delayed in humans and change the FDA indications to allow for next generation interventions. He is a founder of CohBar Inc. (now public company) and Medical Advisor for Life Biosciences. He is on the board of AFAR and CohBar He has been featured in major papers, TV program and documentaries (TEDx and TEDMED) and has been consulting or presented the promise for targeting aging at The Singapore Prime Minister Office, several International Banks, The Vatican, Pepsico, Milkin Institute, The Economist and Wired Magazine.

Liz Parrish

Details coming soon.

Declan Doogan

Details coming soon.

Laura Demming

Details coming soon.

VENUE AND TICKET INFORMATION

VENUE

Science Gallery London
Great Maze Pond
London SE1 9GU

TICKETS

Standard ticket: 300 GBP

Tickets are strictly limited and available on a first-come, first-served basis.

This event is CPD registered, allowing you to add it to your CV.

SUBSCRIBE